| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 445.45% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 05/25/2023 | 445.45% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 03/31/2023 | 445.45% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 10/19/2022 | 445.45% | HC Wainwright & Co. | $6 → $15 | Maintains | Buy |
What is the target price for Lisata Therapeutics (LSTA)?
The latest price target for Lisata Therapeutics (NASDAQ: LSTA) was reported by HC Wainwright & Co. on August 15, 2023. The analyst firm set a price target for $15.00 expecting LSTA to rise to within 12 months (a possible 445.45% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lisata Therapeutics (LSTA)?
The latest analyst rating for Lisata Therapeutics (NASDAQ: LSTA) was provided by HC Wainwright & Co., and Lisata Therapeutics reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Lisata Therapeutics (LSTA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lisata Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lisata Therapeutics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating Lisata Therapeutics (LSTA) correct?
While ratings are subjective and will change, the latest Lisata Therapeutics (LSTA) rating was a reiterated with a price target of $0.00 to $15.00. The current price Lisata Therapeutics (LSTA) is trading at is $2.75, which is within the analyst's predicted range.